Join
Live feed
·
PRReleasevia Quantisnow
NeuroSense Therapeutics Ltd. logo

NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones

ByQuantisnow·Wall Street's wire, on your screen.
NRSN· NeuroSense Therapeutics Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRSN (NeuroSense Therapeutics Ltd.) and more on Quantisnow.